Experimental Drug Might Beat Aspirin in Preventing Repeat Strokes: Study
It’s not yet FDA-approved, but apixaban cut clot risk caused by abnormal heartbeatContinue Reading
It’s not yet FDA-approved, but apixaban cut clot risk caused by abnormal heartbeatContinue Reading
CD117-positive gastrointestinal stromal tumorsContinue Reading
Errors in packaging could cause accidental pregnancies, company warnsContinue Reading
Immunization schedules for meningitis, flu also updatedContinue Reading
Especially true for current or former smokers, researchers sayContinue Reading
Therapy zeroes in on defective protein, agency saysContinue Reading
First drug to target underlying cause of chronic diseaseContinue Reading
Cholesterol-lowering drugs reduce cardiovascular events, death for both sexes, researchers sayContinue Reading
Pill is intended for advanced cases or those unsuitable for surgery, radiationContinue Reading
The most common skin cancerContinue Reading
More research needed into unconfirmed association between antiretrovirals and cleft lip/palateContinue Reading
Doctors seeing more women taking illicit drugs, prescription painkillers during pregnancyContinue Reading
Inlyta is for people who don’t respond to another drugContinue Reading
© 2021 TheHealthCast.com - All Rights Reserved.